122 related articles for article (PubMed ID: 24086071)
1. Comparison of combined transcatheter arterial chemoembolization and radiofrequency ablation with surgical resection by using propensity score matching in patients with hepatocellular carcinoma within Milan criteria.
Takuma Y; Takabatake H; Morimoto Y; Toshikuni N; Kayahara T; Makino Y; Yamamoto H
Radiology; 2013 Dec; 269(3):927-37. PubMed ID: 24086071
[TBL] [Abstract][Full Text] [Related]
2. The role of adjuvant transcatheter arterial chemoembolization following repeated curative resection/ablation for hepatocellular carcinoma with early recurrence: a propensity score matching analysis.
Huang K; Qian T; Chen W; Lao M; Li H; Lin WC; Chen BW; Bai X; Gao S; Ma T; Liang T
BMC Cancer; 2024 May; 24(1):620. PubMed ID: 38773564
[TBL] [Abstract][Full Text] [Related]
3. Transarterial chemoembolization for early stage hepatocellular carcinoma decrease local tumor control and overall survival compared to radiofrequency ablation.
Hocquelet A; Seror O; Blanc JF; Frulio N; Salut C; Nault JC; Trillaud H
Oncotarget; 2017 May; 8(19):32190-32200. PubMed ID: 27793027
[TBL] [Abstract][Full Text] [Related]
4. Rescue therapy for local tumor progression after radiofrequency ablation of small hepatocellular carcinoma: a comparison between repeated ablation and transcatheter arterial chemoembolization.
Cha DI; Lee MW; Ahn SH; Song KD; Kang TW; Sinn DH; Rhim H
Br J Radiol; 2023 Jun; 96(1146):20211037. PubMed ID: 37017490
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis of potentially curative and combination treatments for hepatocellular carcinoma with person-level data in a Canadian setting.
Thein HH; Isaranuwatchai W; Qiao Y; Wong K; Sapisochin G; Chan KKW; Yoshida EM; Earle CC
Cancer Med; 2017 Sep; 6(9):2017-2033. PubMed ID: 28791798
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Surgical Resection and Radiofrequency Ablation in Elderly Patients with Hepatocellular Carcinoma.
Kim JI; Lee J; Choi GH; Lee MW; Park DA; Yoo JJ
Dig Dis Sci; 2024 Mar; 69(3):1055-1067. PubMed ID: 38300416
[TBL] [Abstract][Full Text] [Related]
7. Comparison of surgical resection and transcatheter arterial chemoembolization for large hepatocellular carcinoma: a systematic review and meta-analysis.
Zhou L; Zhang M; Chen S
Ann Hepatol; 2023; 28(2):100890. PubMed ID: 36574929
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the effectiveness of surgical resection and ablation for the treatment of early-stage hepatocellular carcinoma: A retrospective cohort study.
Yang B; Xi X; Yu H; Jiang H; Liang Z; Smayi A; Wu B; Yang Y
Cancer Rep (Hoboken); 2024 Mar; 7(3):e2030. PubMed ID: 38488487
[TBL] [Abstract][Full Text] [Related]
9. Watch-and-wait strategy vs. resection in patients with radiologic complete response after conversion therapy for initially unresectable hepatocellular carcinoma: a propensity score-matching comparative study.
Li B; Wang C; He W; Qiu J; Zheng Y; Zou R; Lin Z; Shi Y; Yuan Y; Zhang R; Zhang C; Chen M; Lau WY; Yuan Y
Int J Surg; 2024 May; 110(5):2545-2555. PubMed ID: 38329081
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of radiofrequency ablation vs. transcatheter arterial embolization for hepatic hemangiomas.
Li J; Zhang S; Ning C; Li G; Guo S
Eur J Gastroenterol Hepatol; 2024 Jun; 36(6):750-757. PubMed ID: 38555605
[TBL] [Abstract][Full Text] [Related]
11. Postoperative adjuvant transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond the Milan criteria: a retrospective analysis.
Dong ZR; Zhang PF; Wang CH; Zhang C; Cai JB; Shi GM; Ke AW; Sun HC; Qiu SJ; Zhou J; Fan J
Am J Cancer Res; 2015; 5(1):450-7. PubMed ID: 25628953
[TBL] [Abstract][Full Text] [Related]
12. Optimizing Survival Benefit by Surgical Resection by the Seven-Eleven Criteria in Barcelona Clinic Liver Cancer Stage A/B Hepatocellular Carcinoma beyond the Milan Criteria.
Huang CT; Chu YL; Su TH; Huang SC; Tseng TC; Hsu SJ; Liao SH; Hong CM; Liu CH; Yang HC; Liu CJ; Chen PJ; Kao JH
Liver Cancer; 2023 Dec; 12(6):539-549. PubMed ID: 38476293
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of Salvage Surgery Versus Non-Salvage Surgery for Initially Unresectable Hepatocellular Carcinoma After Conversion Therapy with Transcatheter Arterial Chemoembolization Combined with Lenvatinib Plus Anti-PD-1 Antibody: A Multicenter Retrospective Study.
Wu JY; Wu JY; Fu YK; Ou XY; Li SQ; Zhang ZB; Zhou JY; Li B; Wang SJ; Chen YF; Yan ML
Ann Surg Oncol; 2024 May; 31(5):3073-3083. PubMed ID: 38316732
[TBL] [Abstract][Full Text] [Related]
14. Comparison of repeated surgical resection and radiofrequency ablation for small recurrent hepatocellular carcinoma after primary resection.
Sun WC; Chen IS; Liang HL; Tsai CC; Chen YC; Wang BW; Lin HS; Chan HH; Hsu PI; Tsai WL; Cheng JS
Oncotarget; 2017 Nov; 8(61):104571-104581. PubMed ID: 29262662
[TBL] [Abstract][Full Text] [Related]
15. Comparison of outcomes between SBRT, yttrium-90 radioembolization, transarterial chemoembolization, and radiofrequency ablation as bridge to transplant for hepatocellular carcinoma.
Mohamed M; Katz AW; Tejani MA; Sharma AK; Kashyap R; Noel MS; Qiu H; Hezel AF; Ramaraju GA; Dokus MK; Orloff MS
Adv Radiat Oncol; 2016; 1(1):35-42. PubMed ID: 28799575
[TBL] [Abstract][Full Text] [Related]
16. Development of machine learning-based clinical decision support system for hepatocellular carcinoma.
Choi GH; Yun J; Choi J; Lee D; Shim JH; Lee HC; Chung YH; Lee YS; Park B; Kim N; Kim KM
Sci Rep; 2020 Sep; 10(1):14855. PubMed ID: 32908183
[TBL] [Abstract][Full Text] [Related]
17. Treatment and outcomes of hepatocellular carcinoma in patients with Sickle cell disease: a population-based study in the U.S.
Barbetta A; Goldbeck C; Lim A; Martin SP; Kahn JA; Sheikh MR; Emamaullee J
HPB (Oxford); 2022 Feb; 24(2):234-243. PubMed ID: 34294525
[TBL] [Abstract][Full Text] [Related]
18. Cost-Effectiveness Comparison of Carbon-Ion Radiation Therapy and Transarterial Chemoembolization for Hepatocellular Carcinoma.
Okazaki S; Shibuya K; Shiba S; Takura T; Ohno T
Adv Radiat Oncol; 2024 Apr; 9(4):101441. PubMed ID: 38778825
[TBL] [Abstract][Full Text] [Related]
19. Long-term oral administration of Huaier granules improves survival outcomes in hepatocellular carcinoma patients within Milan criteria following microwave ablation: a propensity score matching and stabilized inverse probability weighting analysis.
Xie K; Ma M; Xu F
Front Pharmacol; 2024; 15():1336347. PubMed ID: 38774215
[TBL] [Abstract][Full Text] [Related]
20. Heavy Smoking Increases Early Mortality Risk in Patients with Hepatocellular Carcinoma after Curative Treatment.
Lee J; Choi JY; Lee SK
J Liver Cancer; 2024 Jun; ():. PubMed ID: 38852989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
